Cognitive deficit as a consequence of general anesthesia in ophthalmic surgery in postoperative patients
This study considered the influence of the chosen method of analgesia on the state of cognitive functions in the postoperative period. Cognitive status analysis was performed using neuropsychological testing: Frontal Assessment Battery (FAB) and Mini-Mental State Examination (MMSE). The examination was performed in several stages: the day before surgery, 6 hours after it and on day 21 of the postoperative period. Patients were divided into two groups: group d received general anesthesia with the addition of dexmedetomidine for 40 minutes before surgery, anesthesia was maintained with sevoflurane-oxygen mixture on a small gas flow. In group b, the method of general anesthesia was supplemented by the pterygopalatine fossa blockade for 20 minutes prior to the intervention. The groups were statistically comparable in terms of age and sex. Evaluation of the depth of analgesia was performed using analgesia nociception index, evaluation of the depth of anesthesia — with bispectral index. The result of the study showed that, according to neuropsychological testing on the MMSE and FAB, the indicators were more reduced in the postoperative period when using a combination of general anesthesia and the pterygopalatine fossa blockade than in the group received dexmedetomidine as a component of multimodal analgesia (p < 0.001). According to the examination after 6 hours of the postoperative period in group b, the MMSE indicators decreased by 20.8 %, the FAB — by 28.6 % from baseline. When analyzing the results in group d 6 hours after intervention, the indicators of cognitive status on the MMSE were below baseline by 8.3 %, on the FAB — by 13.3 %. Neuropsychological testing on day 21 using the MMSE and FAB showed recovery of cognitive function in both groups. Conclusion. Cognitive status in ophthalmic patients after penetrating keratoplasty according to the MMSE and FAB in both types of anesthesia differed significantly at the second stage of the study (in 6 hours), and over time (21 days after) differences between the groups of the pterygopalatine fossa blockade and of dexmedetomidine were insignificant (p > 0.05).